DeepMed Research

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Palliative Care Consultations in the Skilled Nursing Facility (SNF) Setting

Not Applicable

Completed

Conditions: Skilled Nursing Facilities
Palliative Care
Advance Care Planning

Interventions: Other: Palliative Care Consultation

First Posted Date: 2019-05-22

Last Posted Date: 2024-07-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 45

Registration Number: NCT03958552

Locations: 🇺🇸
Acts Continuing Care Retirement Communities, Philadelphia, Pennsylvania, United States

Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa

Not Applicable

Terminated

Conditions: Pneumonia

Interventions: Device: Bubble CPAP
Other: Standard Therapy

First Posted Date: 2019-05-09

Last Posted Date: 2020-06-09

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 13

Registration Number: NCT03944551

Locations: 🇲🇱
Center for Vaccine Development - Mali, Bamako, Mali

Dolores One: Maximizing Functional Communication for Adults

Not Applicable

Withdrawn

Conditions: Communication

Interventions: Device: Dolores One

First Posted Date: 2019-05-02

Last Posted Date: 2022-04-15

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03934619

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Effect of Heat on Rivastigmine TDS Products

Early Phase 1

Completed

Conditions: Bioavailability

Interventions: Drug: Rivastigmine (RLD) transdermal patch
Drug: Rivastigmine (generic) transdermal patch

First Posted Date: 2019-04-16

Last Posted Date: 2022-04-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 7

Registration Number: NCT03915626

Locations: 🇺🇸
General Clinical Research Center (GCRC) at the University of Maryland Medical Center, Baltimore, Maryland, United States

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali

Phase 4

Active, not recruiting

Conditions: Stillbirths and Infant Mortality

Interventions: Drug: Azithromycin to pregnant women
Other: Placebo to pregnant women
Other: Placebo to infants
Drug: Azithromycin to infants
Other: No intervention to pregnant women

First Posted Date: 2019-04-10

Last Posted Date: 2023-11-30

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 99700

Registration Number: NCT03909737

Locations: 🇲🇱
Centre pour le Developpement des Vaccins - Mali, Bamako, Mali

Neural Correlates of Hypoalgesia Driven by Observation

Phase 2

Recruiting

Conditions: Virtual Reality
Pain
Placebo

Interventions: Drug: Naloxone
Other: Saline

First Posted Date: 2019-04-01

Last Posted Date: 2024-06-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 182

Registration Number: NCT03897998

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Ideal Pacer Pad Position Study

Not Applicable

Completed

Conditions: Symptomatic Bradycardia

Interventions: Procedure: transcutaneous cardiac pacing

First Posted Date: 2019-04-01

Last Posted Date: 2022-10-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 20

Registration Number: NCT03898050

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

Phase 2

Withdrawn

Conditions: Cannabis Use
Schizophrenia Spectrum Disorders

Interventions: Drug: Cannabidiol (CBD)
Drug: Placebo

First Posted Date: 2019-03-20

Last Posted Date: 2021-04-19

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03883360

Locations: 🇺🇸
Sheppard Pratt Health System, Baltimore, Maryland, United States
🇺🇸
Semel Institute for Neuroscience and Human Behavior, Los Angeles, California, United States
🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States

Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease

Phase 4

Completed

Conditions: Parkinson Disease
Parkinson Disease Dementia

Interventions: Drug: Rivastigmine transdermal patch

First Posted Date: 2019-02-15

Last Posted Date: 2023-12-20

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 31

Registration Number: NCT03840837

Locations: 🇺🇸
University of Maryland School of Medicine, Dept. of Neurology, Baltimore, Maryland, United States

CGM/Clarity Use, Glycemic Control and Clinical Outcomes

Not Applicable

Withdrawn

Conditions: Hyperglycemia
Diabetes Mellitus
Hypoglycemia

Interventions: Other: Point of Care (POC) blood glucose
Device: Continuous glucose Monitoring Devices and Clarity Software

First Posted Date: 2019-02-01

Last Posted Date: 2024-11-26

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT03827434

Locations: 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy